54.227.97.219
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Sarcoma

Adverse events common in patients with epithelioid sarcoma receiving systemic therapies

More than half of patients receiving systemic therapies for the treatment of advanced epithelioid sarcoma (ES) experience adverse events, according to a study. In this retrospective study, the medical records of 74 patients with advanced ES who were starting first-line or ≥2 lines of systemic therapy, were reviewed. In total,...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-